Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Timing profit-taking in retirement rebalancing helps lock in gains while preserving the plan. This guide highlights practical timing cues and rules.
17,033 articlesA major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
When insiders trade, investors pay attention. This article breaks down what seacoast banking corp. sells signals, how...
A big move by an asset manager can ripple through a stock’s price and its story. This article explains what asset man...
CFTC staff released a new FAQ detailing how crypto assets can be used as collateral for derivatives, including specif...
NVIDIA stock investors just received a wave of optimism from analysts who see substantial upside as AI adoption accel...
As AI workloads surge, memory becomes a key battleground. This guide breaks down Micron and Sandisk fundamentals, gro...
As defense spending surging reshapes markets, two ETFs—MISL and ITA—offer different paths to ride the trend. This gui...
SQQQ has endured sustained daily reset losses that compound over time, erasing most of its value even as the Nasdaq-1...
A member of Congress with a substantial AI-focused portfolio has surged 72% this year, drawing investor attention to ...
Two tech giants define growth storytelling in 2026: one leads cloud security, the other powers AI infrastructure. Thi...
A Life360 board director recently sold several thousand shares after exercising options, timing that coincides with a...
Bitcoin remains above $66,000 as March begins, with analysts weighing a bitcoin high-stakes march: $120k scenario ami...